Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Soapbox Science is coming to Oxford for the third year running thanks to a collaboration between the University of Oxford and Oxford Brookes University.

Scientists at 2017 'Soapbox Science' event

Soapbox Science is a novel public outreach platform for promoting women scientists and the science they do. Their events transform public areas into an arena for public learning and scientific debate; they follow the format of London Hyde Park’s Speaker’s Corner, which is historically an arena for public debate. The aim of Soapbox Science is to give everyone the opportunity to enjoy, learn from, heckle, question, probe, interact with and be inspired by leading scientists.

Two previous Soapbox Science events in Oxford have transformed Cornmarket Street and Magdalen College School into an arena for science communication and public interaction, and this Saturday 28 July the next event will be held at Bonn Square in Oxford from 1pm – 4pm.

A number of scientists from across the Medical Sciences Division will be taking part in this year’s Soapbox Science, exploring the following topics:

Other scientists will explore topics including robot doctors and venomous primates – find out more and come along.

Soapbox Science Oxford is a collaboration between the University of Oxford and Oxford Brookes University. It is organised by Carlyn Samuel (Interdisciplinary centre of of Conservation Science at the University of Oxford) Ravinder Kander (department of Biological and Medicinal Sciences, Oxford Brookes University) and Dong Liu (Department of Materials, University of Oxford).

Similar stories

Potential for radiotherapy and VTP multimodality therapy for prostate cancer

A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System

A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University as part of a successful NHSx Artificial Intelligence Health and Care Award application.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.